Evidence check: FT3 in the context of Blutzucker

The evidence for FT3 (free triiodothyronine) in the context of blood glucose is unclear. FT3 is the active thyroid hormone and a marker of peripheral thyroid function. Mechanistically, thyroid hormones influence glucose metabolism – e.g., by increasing hepatic glucose production and modulating insulin sensitivity. However, FT3 alone is not a validated biomarker for blood sugar dysregulation. Observational studies report inconsistent associations between FT3 and fasting glucose or HbA1c, often confounded by age, BMI, or thyroid disease. In clinical practice, FT3 is used for thyroid assessment, not for glycemic control. No strong causal link has been established. For reliable blood sugar monitoring, established parameters like fasting glucose, HbA1c, and oral glucose tolerance test are recommended. The evidence level is best described as unclear – mechanistic plausibility and some observational data exist, but no robust clinical evidence supports FT3 as a standalone marker for blood glucose issues.